Clinical Decision Support System Market

Clinical Decision Support System Market (Usage Based: Knowledge-based Systems, Expert Laboratory Information Systems, and Machine Learning Systems; Mode of Advice: Passive CDSS and Active CDSS) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Clinical Decision Support System Market Outlook 2031

  • The global clinical decision support system market was valued at US$ 1.2 Bn in 2021
  • The global market is projected to grow at a CAGR of 8.8% from 2022 to 2031
  • The global clinical decision support system market is anticipated to exceed value of US$ 2.3 Bn by 2031

Analysts’ Viewpoint on Global Clinical Decision Support System Market Scenario

Computerized clinical decision support systems, or CDSS, represent a paradigm shift in healthcare today. CDSS is used to assist physicians in their complex decision-making processes. It is aimed at improving healthcare delivery by enhancing medical decisions with targeted clinical information, patient information, and other health-related information mainly facilitated by the increasing global adoption of electronic medical records with advanced capabilities. Hence, the clinical decision support system market is expected to witness growth during the forecast period. Implementation of an effective system management program and increase in technological advancements, such as software integration with electronic health records, are likely to further boost the growth of the clinical decision support system market.

Overview of Global Clinical Decision Support System Market

Clinical decision support system is an administrative as well as clinical tool that helps in improving operational efficiency of healthcare practices. Hospitals and clinics are required to handle large volume of patient information both administrative as well as clinical information. In order to handle the large volume of data, medical professionals and front office staff are always in search of an effective way to record, store, and improve access to patient information in an efficient manner. A clinical decision support system aids medical professionals and patients to streamline the workflows of medical practices and improve overall operational efficiency as well as patient care.

Physician recommendation for updating systems with alert systems and new technological innovation by different key players are likely to accelerate the growth of the global clinical decision support system market. Technological advancements such as software integration with other electronic health records are projected to fuel the growth of the global clinical decision support system market.

Technological Advancements in CDSS to Drive Global Market

Rise in technological advancements in CDSS, high awareness among patients, and increase in investments in healthcare IT solutions accelerate the growth of the global clinical decision support system market. A surge in group medical practices has been observed in the U.S., which is expected to fuel the growth of the cloud based clinical decision support system in the country during the forecast period.

Technological advancements in CDSS are expected to propel the clinical decision support system market in Asia Pacific, Latin America, and Middle East & Africa during the forecast period.

Knowledge-based Systems Segment to Dominate Global Clinical Decision Support System Market

The global clinical decision support system market has been segmented based on usage based, application, mode of advice, delivery model, end-user, and region. In terms of usage based, the global clinical decision support system market has been classified into knowledge-based systems, expert laboratory information systems, and machine learning systems.

knowledge-based systems segment dominates the global market. The large share and high growth of this segment can be attributed to several beneficial functionalities of knowledge-based CDSS, such as helping clinicians with knowledge-based reasoning to make clinical decisions in the face of uncertainties. In 2020, the knowledge-based CDSS segment accounted for the largest share of 61% of the market. This segment is also estimated to register the highest CAGR of 9.2% during the forecast period.

There has been an increase in support in the development of innovative clinical decision support systems; for instance, Boston Children’s Hospital launched a clinical decision support innovation Challenge in which the winner receives rewards in the form of direct costs (around US$ 50,000), strategic project management support. and R&D software development support. Moreover, rise in collaboration of hospitals and clinics with healthcare IT firms and increasing incorporation of machine learning algorithms & AI methods will further support the CDSS Market.

Cloud-based Clinical Decision Support System Aids in Easy Recording, Accessibility; Offers Other Benefits

Traditionally, on-premises and web-based clinical decision support systems were most commonly used in dental practices. On-premises software is associated with purchase of expensive servers and other hardware for data storage and backups. The software is priced on perpetual license model and is highly priced. Cloud-based clinical decision support system enables a user to host clinical applications, allows health information exchange, and data backup & recovery features. These cloud-based clinical decision support systems address specific challenges faced by the multi-location physician group practices as well as for solo practitioners. The cloud-based clinical decision support system facilitates easy recording, storage, and accessibility, and integration and retrieval of both clinical as well as non-clinical data from any point of location with an Internet connection.

Regional Outlook of Global Clinical Decision Support System Market

In terms of region, the global clinical decision support system market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period, accounting for 40% share by 2031. The segment is anticipated to reach US$ 892.66 Mn by 2031.

The U.S. dominated the market in North America due to factors such as technologically advanced research & treatment platforms for diagnosis of chronic diseases, availability of a large number of reimbursement policies, well-established healthcare infrastructure, and increase in development of IT healthcare organizations. Rise in government initiatives and laws regarding usage of devices, and increase in population to drive the clinical decision support system market in the region.

Asia Pacific is projected to be the most attractive market for clinical decision support systems during the forecast period. The market in the region is anticipated to grow at a high CAGR of 10% during the forecast period due to rise in focus of market players on expanding their presence in the region to leverage the growth opportunities.

Improvement in healthcare infrastructure and commercialization of electronic health record (HER) in hospitals & clinics, high digital healthcare IT budgets provided by society as funds for IT development, and government initiatives to promote digital healthcare facilities contributed to the leading share of these regions.

Analysis of Key Players in Global Clinical Decision Support System Market

Key players operating in the global clinical decision support system market include Allscripts Healthcare Solutions, Inc., First Databank, Inc., Truven Health Analytics, Cerner, Philips Healthcare, Siemens Healthcare, Optum, Inc. (UnitedHealth Group), GE Healthcare, and Epic Systems Corporation, Inc.

Each of these players has been profiled in the clinical decision support system market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.

Key Developments in Global Clinical Decision Support System Market

  • In January 2018, Allscripts Healthcare Solutions, Inc. acquired Practice Fusion for US$ 100 Mn to diversify Big Data insights and analytics, data sharing technologies, and clinical trial solutions portfolio
  • In January 2018, Siemens Healthcare Private Limited completed the acquisition of Fast Track Diagnostics (FTD) to diversify Siemens Healthineers’ molecular diagnostics portfolio
  • In May 2017, Cerner announced a collaboration with Fusionetics, a provider of evidence-based performance healthcare solutions, to integrate Fusionetics assessment programming with Cerner’s HealtheAthlete, a web-based platform designed to provide an in-depth management of athletes’ health and treatment for sports medicine staff

Global Clinical Decision Support System Market Snapshot

Attribute

Detail

Market Size Value in 2021 (Base Year)

US$ 1.2 Bn

Market Forecast Value in 2031

US$ 2.3 Bn

Growth Rate (CAGR)

8.8%

Forecast Period

2022–2031

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Usage Based
    • Knowledge-based Systems
    • Expert Laboratory Information Systems
    • Machine Learning Systems
  • Mode of Advice
    • Passive CDSS
    • Active CDSS
  • Delivery Model
    • On-premises
    • Web-based
    • Cloud-based
  • Application
    • Drug Databases
    • Care Plans
    • Diagnostic Decision Support
    • Disease Reference
    • Others
  • End-user
    • Hospitals
    • Diagnostic Centers
    • Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the clinical decision support system market in 2021?

The clinical decision support system market was valued at US$ 1.2 Bn in 2021.

How big will be the clinical decision support system market in 2031?

The clinical decision support system market is projected to cross over US$ 2.3 Bn by 2031.

What was the CAGR of the clinical decision support system market during the forecast period (2017-2021)?

The clinical decision support system market grew at a CAGR of 8% from 2017 to 2021.

What will be the CAGR of the clinical decision support system market during the forecast period (2022–2031)?

The clinical decision support system market is anticipated to grow at a CAGR of 8.8% from 2022 to 2031.

Who are the prominent players in the clinical decision support system market?

Prominent players in the clinical decision support system market are Allscripts Healthcare Solutions, Inc., First Databank, Inc., Truven Health Analytics, Cerner, Philips Healthcare, Siemens Healthcare, Optum, Inc. (UnitedHealth Group), GE Healthcare, and Epic Systems Corporation, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Clinical Decision Support System Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Usage Based Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Clinical Decision Support System Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)

        5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Clinical Decision Support System Market Analysis and Forecast. by Usage Based

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Usage Based, 2017–2031

            6.3.1. Knowledge-based Systems

            6.3.2. Expert Laboratory Information Systems

            6.3.3. Machine Learning Systems

        6.4. Market Attractiveness Analysis, by Usage Based

    7. Global Clinical Decision Support System Market Analysis and Forecast. by Mode of Advice

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Mode of Advice, 2017–2031

            7.3.1. Passive CDSS

            7.3.2. Active CDSS

        7.4. Market Attractiveness Analysis, by Mode of Advice

    8. Global Clinical Decision Support System Market Analysis and Forecast. by Delivery Model

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Delivery Model, 2017–2031

            8.3.1. On-premises

            8.3.2. Web-based

            8.3.3. Cloud-based

        8.4. Market Attractiveness Analysis, by Delivery Model

    9. Global Clinical Decision Support System Market Analysis and Forecast. by Application

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by Application, 2017–2031

            9.3.1. Drug Databases

            9.3.2. Care Plans

            9.3.3. Diagnostic Decision Support

            9.3.4. Disease Reference

            9.3.5. Others

        9.4. Market Attractiveness Analysis, by Application

    10. Global Clinical Decision Support System Market Analysis and Forecast. by End-user

        10.1. Introduction & Definition

        10.2. Key Findings / Developments

        10.3. Market Value Forecast, by End-user, 2017–2031

            10.3.1. Hospitals

            10.3.2. Diagnostic Centers

            10.3.3. Clinics

            10.3.4. Others

        10.4. Market Attractiveness Analysis, by End-user

    11. Global Clinical Decision Support System Market Analysis and Forecast. by Region

        11.1. Key Findings

        11.2. Market Value Forecast, by Region

            11.2.1. North America

            11.2.2. Europe

            11.2.3. Asia Pacific

            11.2.4. Latin America

            11.2.5. Middle East & Africa

        11.3. Market Attractiveness Analysis, by Region

    12. North America Clinical Decision Support System Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Usage Based, 2017–2031

            12.2.1. Knowledge-based Systems

            12.2.2. Expert Laboratory Information Systems

            12.2.3. Machine Learning Systems

        12.3. Market Value Forecast, by Mode of Advice, 2017–2031

            12.3.1. Passive CDSS

            12.3.2. Active CDSS

        12.4. Market Value Forecast, by Delivery Model, 2017–2031

            12.4.1. On-premises

            12.4.2. Web-based

            12.4.3. Cloud-based

        12.5. Market Value Forecast, by Application, 2017–2031

            12.5.1. Drug Databases

            12.5.2. Care Plans

            12.5.3. Diagnostic Decision Support

            12.5.4. Disease Reference

            12.5.5. Others

        12.6. Market Value Forecast, by End-user, 2017–2031

            12.6.1. Hospitals

            12.6.2. Diagnostic Centers

            12.6.3. Clinics

            12.6.4. Others

        12.7. Market Value Forecast, by Country, 2017–2031

            12.7.1. U.S.

            12.7.2. Canada

        12.8. Market Attractiveness Analysis

            12.8.1. By Usage Based

            12.8.2. By Mode of Advice

            12.8.3. By Delivery Model

            12.8.4. By Application

            12.8.5. By End-user

            12.8.6. By Country

    13. Europe Clinical Decision Support System Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Usage Based, 2017–2031

            13.2.1. Knowledge-based Systems

            13.2.2. Expert Laboratory Information Systems

            13.2.3. Machine Learning Systems

        13.3. Market Value Forecast, by Mode of Advice, 2017–2031

            13.3.1. Passive CDSS

            13.3.2. Active CDSS

        13.4. Market Value Forecast, by Delivery Model, 2017–2031

            13.4.1. On-premises

            13.4.2. Web-based

            13.4.3. Cloud-based

        13.5. Market Value Forecast, by Application, 2017–2031

            13.5.1. Drug Databases

            13.5.2. Care Plans

            13.5.3. Diagnostic Decision Support

            13.5.4. Disease Reference

            13.5.5. Others

        13.6. Market Value Forecast, by End-user, 2017–2031

            13.6.1. Hospitals

            13.6.2. Diagnostic Centers

            13.6.3. Clinics

            13.6.4. Others

        13.7. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.7.1. Germany

            13.7.2. U.K.

            13.7.3. France

            13.7.4. Spain

            13.7.5. Italy

            13.7.6. Rest of Europe

        13.8. Market Attractiveness Analysis

            13.8.1. By Usage Based

            13.8.2. By Mode of Advice

            13.8.3. By Delivery Model

            13.8.4. By Application

            13.8.5. By End-user

            13.8.6. By Country/Sub-region

    14. Asia Pacific Clinical Decision Support System Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Usage Based, 2017–2031

            14.2.1. Knowledge-based Systems

            14.2.2. Expert Laboratory Information Systems

            14.2.3. Machine Learning Systems

        14.3. Market Value Forecast, by Mode of Advice, 2017–2031

            14.3.1. Passive CDSS

            14.3.2. Active CDSS

        14.4. Market Value Forecast, by Delivery Model, 2017–2031

            14.4.1. On-premises

            14.4.2. Web-based

            14.4.3. Cloud-based

        14.5. Market Value Forecast, by Application, 2017–2031

            14.5.1. Drug Databases

            14.5.2. Care Plans

            14.5.3. Diagnostic Decision Support

            14.5.4. Disease Reference

            14.5.5. Others

        14.6. Market Value Forecast, by End-user, 2017–2031

            14.6.1. Hospitals

            14.6.2. Diagnostic Centers

            14.6.3. Clinics

            14.6.4. Others

        14.7. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.7.1. China

            14.7.2. Japan

            14.7.3. India

            14.7.4. Australia & New Zealand

            14.7.5. Rest of Asia Pacific

        14.8. Market Attractiveness Analysis

            14.8.1. By Usage Based

            14.8.2. By Mode of Advice

            14.8.3. By Delivery Model

            14.8.4. By Application

            14.8.5. By End-user

            14.8.6. By Country/Sub-region

    15. Latin America Clinical Decision Support System Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Usage Based, 2017–2031

            15.2.1. Knowledge-based Systems

            15.2.2. Expert Laboratory Information Systems

            15.2.3. Machine Learning Systems

        15.3. Market Value Forecast, by Mode of Advice, 2017–2031

            15.3.1. Passive CDSS

            15.3.2. Active CDSS

        15.4. Market Value Forecast, by Delivery Model, 2017–2031

            15.4.1. On-premises

            15.4.2. Web-based

            15.4.3. Cloud-based

        15.5. Market Value Forecast, by Application, 2017–2031

            15.5.1. Drug Databases

            15.5.2. Care Plans

            15.5.3. Diagnostic Decision Support

            15.5.4. Disease Reference

            15.5.5. Others

        15.6. Market Value Forecast, by End-user, 2017–2031

            15.6.1. Hospitals

            15.6.2. Diagnostic Centers

            15.6.3. Clinics

            15.6.4. Others

        15.7. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.7.1. Brazil

            15.7.2. Mexico

            15.7.3. Rest of Latin America

        15.8. Market Attractiveness Analysis

            15.8.1. By Usage Based

            15.8.2. By Mode of Advice

            15.8.3. By Delivery Model

            15.8.4. By Application

            15.8.5. By End-user

            15.8.6. By Country/Sub-region

    16. Middle East & Africa Clinical Decision Support System Market Analysis and Forecast

        16.1. Introduction

            16.1.1. Key Findings

        16.2. Market Value Forecast, by Usage Based, 2017–2031

            16.2.1. Knowledge-based Systems

            16.2.2. Expert Laboratory Information Systems

            16.2.3. Machine Learning Systems

        16.3. Market Value Forecast, by Mode of Advice, 2017–2031

            16.3.1. Passive CDSS

            16.3.2. Active CDSS

        16.4. Market Value Forecast, by Delivery Model, 2017–2031

            16.4.1. On-premises

            16.4.2. Web-based

            16.4.3. Cloud-based

        16.5. Market Value Forecast, by Application, 2017–2031

            16.5.1. Drug Databases

            16.5.2. Care Plans

            16.5.3. Diagnostic Decision Support

            16.5.4. Disease Reference

            16.5.5. Others

        16.6. Market Value Forecast, by End-user, 2017–2031

            16.6.1. Hospitals

            16.6.2. Diagnostic Centers

            16.6.3. Clinics

            16.6.4. Others

        16.7. Market Value Forecast, by Country/Sub-region, 2017–2031

            16.7.1. GCC Countries

            16.7.2. South Africa

            16.7.3. Rest of Middle East & Africa

        16.8. Market Attractiveness Analysis

            16.8.1. By Usage Based

            16.8.2. By Mode of Advice

            16.8.3. By Delivery Model

            16.8.4. By Application

            16.8.5. By End-user

            16.8.6. By Country/Sub-region

    17. Competition Landscape

        17.1. Market Player - Competition Matrix

        17.2. Market Share Analysis, by Company, 2021

        17.3. Company Profiles

            17.3.1. Allscripts Healthcare Solutions, Inc.

                17.3.1.1. Company Overview (HQ, Business Segments, Employee)

                17.3.1.2. Product Portfolio

                17.3.1.3. SWOT Analysis

                17.3.1.4. Strategic Overview

            17.3.2. First Databank, Inc.

                17.3.2.1. Company Overview (HQ, Business Segments, Employee)

                17.3.2.2. Product Portfolio

                17.3.2.3. SWOT Analysis

                17.3.2.4. Strategic Overview

            17.3.3. Truven Health Analytics

                17.3.3.1. Company Overview (HQ, Business Segments, Employee)

                17.3.3.2. Product Portfolio

                17.3.3.3. SWOT Analysis

                17.3.3.4. Strategic Overview

            17.3.4. Cerner

                17.3.4.1. Company Overview (HQ, Business Segments, Employee)

                17.3.4.2. Product Portfolio

                17.3.4.3. SWOT Analysis

                17.3.4.4. Strategic Overview

            17.3.5. Philips Healthcare

                17.3.5.1. Company Overview (HQ, Business Segments, Employee)

                17.3.5.2. Product Portfolio

                17.3.5.3. SWOT Analysis

                17.3.5.4. 17.3.5.4.Strategic Overview

            17.3.6. Siemens Healthcare

                17.3.6.1. Company Overview (HQ, Business Segments, Employee)

                17.3.6.2. Product Portfolio

                17.3.6.3. SWOT Analysis

                17.3.6.4. Strategic Overview

            17.3.7. Optum, Inc. (UnitedHealth Group)

                17.3.7.1. Company Overview (HQ, Business Segments, Employee)

                17.3.7.2. Product Portfolio

                17.3.7.3. SWOT Analysis

                17.3.7.4. Strategic Overview

            17.3.8. GE Healthcare

                17.3.8.1. Company Overview (HQ, Business Segments, Employee)

                17.3.8.2. Product Portfolio

                17.3.8.3. SWOT Analysis

                17.3.8.4. Strategic Overview

            17.3.9. Epic Systems Corporation Inc.

                17.3.9.1. Company Overview (HQ, Business Segments, Employee)

                17.3.9.2. Product Portfolio

                17.3.9.3. SWOT Analysis

                17.3.9.4. Strategic Overview

    List of Tables

    Table 01: Global Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031

    Table 02: Global Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031

    Table 03: Global Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 04: Global Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031

    Table 05: Global Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 06: Global Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by Region, 2017-2031

    Table 07: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country, 2017-2031

    Table 08: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031

    Table 09: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031

    Table 10: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031

    Table 11: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 12: North America Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 13: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 14: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031

    Table 15: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031

    Table 16: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031

    Table 17: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 18: Europe Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 19: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 20: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031

    Table 21: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031

    Table 22: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031

    Table 23: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 24: Asia Pacific Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 25: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 26: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage Based, 2017-2031

    Table 27: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031

    Table 28: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031

    Table 29: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 30: Latin America Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 31: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 32: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Usage, 2017-2031

    Table 33: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Mode of Advice, 2017-2031

    Table 34: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Delivery Model, 2017-2031

    Table 35: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 36: Middle East & Africa Clinical Decision Support Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    List of Figures

    Figure 01: Global Clinical Decision Support Systems Market Size (US$ Mn) Forecast, 2017-2031

    Figure 03: Global Clinical Decision Support Systems Market Value Share, by Region, 2021

    Figure 05: Global Clinical Decision Support Systems Market Value Share, by Application, 2021

    Figure 02: Global Clinical Decision Support Systems Market Value Share, by Usage Based, 2021

    Figure 04: Global Clinical Decision Support Systems Market Value Share, by End-user, 2021

    Figure 03: Global Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2021

    Figure 05: Global Clinical Decision Support Systems Market Value Share, by Delivery Model, 2021

    Figure 08: Global Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031

    Figure 09: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Knowledge-based Systems, 2017-2031

    Figure 10: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Expert Laboratory Information Systems, 2017-2031

    Figure 11: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Machine Learning Systems, 2017-2031

    Figure 12: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031

    Figure 13: Global Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031

    Figure 14: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031

    Figure 15: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Passive CDSS, 2017-2031

    Figure 16: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Active CDSS, 2017-2031

    Figure 17: Global Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031

    Figure 18: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031

    Figure 20: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Care Plans, 2017-2031

    Figure 19: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Databases, 2017-2031

    Figure 21: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Decision Support, 2017-2031

    Figure 22: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disease Reference, 2017-2031

    Figure 23: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031

    Figure 24: Global Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031

    Figure 25: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031

    Figure 27: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Web-based, 2017-2031

    Figure 26: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by On-premises, 2017-2031

    Figure 28: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cloud-based, 2017-2031

    Figure 29: Global Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031

    Figure 30: Global Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031

    Figure 32: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Centers, 2017-2031

    Figure 31: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031

    Figure 33: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), Clinics, 2017-2031

    Figure 34: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017-2031

    Figure 35: Global Clinical Decision Support Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031

    Figure 36: Global Clinical Decision Support Systems Market Value Share, by Region, 2017 and 2031

    Figure 37: Global Clinical Decision Support Systems Market Attractiveness Analysis, by Region, 2017–2031

    Figure 39: North America Clinical Decision Support Systems Market Value Share, by Country, 2017–2031

    Figure 38: North America Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031

    Figure 40: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Country, 2017–2031

    Figure 41: North America Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031

    Figure 42: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031

    Figure 43: North America Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031

    Figure 44: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031

    Figure 45: North America Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031

    Figure 46: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031

    Figure 47: North America Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031

    Figure 48: North America Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031

    Figure 49: North America Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031

    Figure 50: North America Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031

    Figure 52: Europe Clinical Decision Support Systems Market Value Share, by Country/Sub-region, 2017–2031

    Figure 51: Europe Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031

    Figure 53: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

    Figure 54: Europe Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031

    Figure 55: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031

    Figure 56: Europe Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031

    Figure 57: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031

    Figure 58: Europe Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031

    Figure 59: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031

    Figure 60: Europe Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031

    Figure 61: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031

    Figure 62: Europe Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031

    Figure 63: Europe Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031

    Figure 65: Asia Pacific Clinical Decision Support Systems Market Value Share, by Country/Sub-region, 2017–2031

    Figure 64: Asia Pacific Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031

    Figure 66: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

    Figure 67: Asia Pacific Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031

    Figure 68: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031

    Figure 69: Asia Pacific Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031

    Figure 70: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031

    Figure 71: Asia Pacific Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031

    Figure 72: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031

    Figure 73: Asia Pacific Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031

    Figure 74: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031

    Figure 75: Asia Pacific Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031

    Figure 76: Asia Pacific Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031

    Figure 78: Latin America Clinical Decision Support Systems Market Value Share, by Country/Sub-region, 2017–2031

    Figure 77: Latin America Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 79: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

    Figure 80: Latin America Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031

    Figure 81: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031

    Figure 82: Latin America Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031

    Figure 83: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031

    Figure 84: Latin America Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031

    Figure 85: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031

    Figure 86: Latin America Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031

    Figure 87: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031

    Figure 88: Latin America Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031

    Figure 89: Latin America Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031

    Figure 91: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Country/Sub-region, 2017–2031

    Figure 90: Middle East & Africa Clinical Decision Support Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 92: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

    Figure 93: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Usage Based, 2017 and 2031

    Figure 94: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Usage Based, 2017–2031

    Figure 95: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Mode of Advice, 2017 and 2031

    Figure 96: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Mode of Advice, 2017–2031

    Figure 97: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Delivery Model, 2017 and 2031

    Figure 98: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Delivery Model, 2017–2031

    Figure 99: Middle East & Africa Clinical Decision Support Systems Market Value Share, by Application, 2017 and 2031

    Figure 100: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by Application, 2017–2031

    Figure 101: Middle East & Africa Clinical Decision Support Systems Market Value Share, by End-user, 2017 and 2031

    Figure 102: Middle East & Africa Clinical Decision Support Systems Market Attractiveness Analysis, by End-user, 2017–2031

    Figure 103: Global Clinical Decision Support Systems Market Share, by Company, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved